Karissa Gable

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r

Ted M. Burns, Reza Sadjadi, Kimiaki Utsugisawa et al. · Muscle & Nerve · 2016 · 144 citations

Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis

Brian J. Wainger, Eric A. Macklin, Steve Vucic et al. · JAMA Neurology · 2020 · 129 citations · Full text

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

Jack Youngren, Karissa Gable, Cristina Peñaranda et al. · Breast Cancer Research and Treatment · 2005 · 112 citations

Tumor Biology, Breast Oncology, Nordihydroguaiaretic Acid +10

Classical Complement Pathway Inhibition in a “Human‐On‐A‐Chip” Model of Autoimmune Demyelinating Neuropathies

John W. Rumsey, Case Lorance, Max Jackson et al. · Advanced Therapeutics · 2022 · 71 citations · Full text

Chronic Inflammatory, Immunology, Immune Regulation +19